Genes

22 June 2023

From Genes to Proteins: Understanding the Molecular Aspects of Aging and Its Implications for Biorejuvenation

Introduction

Aging is a natural, complex biological process characterized by progressive decline in physiological function and an increase in vulnerability to diseases, such as neurodegenerative diseases, cardiovascular diseases, and cancer (Lopez-Otin et al., 2013). Various genetic and environmental factors contribute to aging, with substantial evidence pointing towards a genetic component as being key in this process (Kennedy et al., 2014). This article aims to dissect the intricate pathway from genes to proteins in the context of aging and its implications for biorejuvenation.

Genetics of Aging

Studies in model organisms such as yeast, nematodes, and fruit flies have identified specific genes, often referred to as longevity genes, whose alteration can extend lifespan. These genes mainly include those involved in insulin/IGF-1 signaling (IIS), Target of Rapamycin (TOR) pathway, sirtuins, and DNA repair mechanisms (Fontana et al., 2010). Additionally, genomic studies in humans, such as the Longevity Genes Project, have identified gene variants associated with exceptional longevity and healthy aging (Barzilai et al., 2012). However, the relationship between genes and aging is not solely a matter of genetics; it also involves epigenetic changes that affect gene expression.

Epigenetics and Aging

Epigenetic changes, including DNA methylation, histone modifications, and non-coding RNA regulation, play critical roles in the aging process (Sen et al., 2016). For instance, the gradual accumulation of DNA methylation changes over time, also known as "epigenetic drift," is considered a hallmark of aging (Jones et al., 2015). A study by Horvath (2013) introduced the concept of an 'epigenetic clock,' which can predict biological age based on DNA methylation levels, suggesting a functional role of these epigenetic changes in aging.

From Genes to Proteins: The Proteome's Role in Aging

The interplay of genetics and epigenetics influences the transcriptome and ultimately the proteome, which plays a critical role in the aging process. Proteostasis, or protein homeostasis, is crucial for maintaining the health and function of cells. Disruptions in proteostasis, such as misfolded or aggregated proteins, are a common characteristic of aging cells and contribute to the pathology of age-related diseases like Alzheimer's (Taylor and Dillin, 2011). Moreover, research indicates that the regulation of protein synthesis, degradation, and post-translational modifications change with age, affecting cellular functions and thus influencing the aging process (López-Otín et al., 2016).

Implications for Biorejuvenation

Understanding the molecular aspects of aging, from genes to proteins, opens up potential strategies for biorejuvenation. One approach is targeting the genetic and epigenetic changes associated with aging, aiming to reverse these changes or modulate their downstream effects. For instance, interventions such as senolytics target senescent cells that accumulate with age and contribute to aging pathology (Zhu et al., 2015).

The modulation of longevity pathways such as IIS, TOR, and sirtuins have also been shown to impact lifespan in various organisms, suggesting their potential as therapeutic targets for biorejuvenation (Kennedy et al., 2014).

Moreover, strategies that enhance proteostasis could potentially delay aging and increase healthspan. For example, boosting the function of the proteasome, a cellular machinery for protein degradation, has been shown to enhance longevity in yeast (Chondrogianni et al., 2015).

Conclusion

The journey from genes to proteins in the context of aging is a complex process that involves an interplay of genetic, epigenetic, and proteomic changes. Understanding these processes at a molecular level can help pave the way for biorejuvenation strategies that aim to reverse, delay, or mitigate the effects of aging, ultimately improving healthspan and quality of life in old age.

References

  1. Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013). The hallmarks of aging. Cell, 153(6), 1194-1217.
  2. Kennedy, B. K., Berger, S. L., Brunet, A., Campisi, J., Cuervo, A. M., Epel, E. S., ... & Rando, T. A. (2014). Geroscience: linking aging to chronic disease. Cell, 159(4), 709-713.
  3. Fontana, L., Partridge, L., & Longo, V. D. (2010). Extending healthy life span—from yeast to humans. Science, 328(5976), 321-326.
  4. Barzilai, N., Huffman, D. M., Muzumdar, R. H., & Bartke, A. (2012). The critical role of metabolic pathways in aging. Diabetes, 61(6), 1315-1322.
  5. Sen, P., Shah, P. P., Nativio, R., & Berger, S. L. (2016). Epigenetic Mechanisms of Longevity and Aging. Cell, 166(4), 822-839.
  6. Jones, M. J., Goodman, S. J., & Kobor, M. S. (2015). DNA methylation and healthy human aging. Aging cell, 14(6), 924-932.
  7. Horvath, S. (2013). DNA methylation age of human tissues and cell types. Genome biology, 14(10), R115.
  8. Taylor, R. C., & Dillin, A. (2011). Aging as an event of proteostasis collapse. Cold Spring Harbor perspectives in biology, 3(5), a004440.
  9. López-Otín, C., Galluzzi, L., Freije, J. M., Madeo, F., & Kroemer, G. (2016). Metabolic Control of Longevity. Cell, 166(4), 802-821.
  10. Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., ... & O'Hara, S. P. (2015). The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs. Aging cell, 14(4), 644-658.
  11. Chondrogianni, N., Petropoulos, I., Grimm, S., Georgila, K., Catalgol, B., Friguet, B., ... & Gonos, E. S. (2015). Protein damage, repair and proteolysis. Molecular Aspects of Medicine, 35, 1-71.